1. Chemotherapeutic Protocols for the Treatment of Gastrointestinal Tract Cancer
   Iago Dillion Lima Cavalcanti, 2022, Chemotherapy Protocols and Infusion Sequence CrossRef
2. Downregulation of NPM expression by Her-2 reduces resistance of gastric cancer to oxaliplatin
   Zhenni Sun et al, 2017, Oncology Letters CrossRef
3. FAP-retargeted Ad5 enables in vivo gene delivery to stromal cells in the tumor microenvironment
   K. Patricia Hartmann et al, 2023, Molecular Therapy CrossRef
4. Pretreatment with Gemcitabine/5-Fluorouracil Enhances the Cytotoxicity of Trastuzumab to HER2-Negative Human Gallbladder Cancer Cells In Vitro and In Vivo
   Wei Wang et al, 2019, BioMed Research International CrossRef
5. Phase II study to evaluate the efficacy of Trastuzumab in combination with Capecitabine and Oxaliplatin in first-line treatment of HER2-positive advanced gastric cancer: HERXO trial
   Fernando Rivera et al, 2019, Cancer Chemotherapy and Pharmacology CrossRef
6. Case studies highlighting the multiple facets of gastric cancer: one diagnosis, multiple approaches
   Caroline Lum et al, 2021, Research and Clinical Applications of Targeting Gastric Neoplasms CrossRef